Joinn Laboratories (China)
Joinn Laboratories (China) Co Ltd is a Chinese non-clinical pharmaceutical safety evaluation and contract research organization (CRO) enterprise headquartered in Beijing, China. The company specializes in providing comprehensive preclinical safety assessment, pharmacological research, toxicology testing, pharmacokinetics, and drug discovery support services for global pharmaceutical and biotechnology corporations. Principal revenue is derived through preclinical contract research service fees and laboratory testing charges. Joinn Laboratories is publicly listed on the Shanghai Stock Exchange and the Hong Kong Stock Exchange.
4 of the funds FundTelligence covers report a position in Joinn Laboratories (China).
- Legal name
- Joinn Laboratories (China) Co Ltd
- Sector
- Health Care
- Country
- China
- Funds holding it
- 4
Funds holding Joinn Laboratories (China)
- BlackRock iShares Healthcare Innovation UCITS ETF — BlackRock · 0.03 % (full portfolio disclosed, October 2026)
- Handelsbanken Global Index Criteria — Handelsbanken · 0.01 % (full portfolio disclosed, September 2026)
- Handelsbanken Emerging Markets Index — Handelsbanken · 0.01 % (full portfolio disclosed, September 2026)
- BlackRock iShares MSCI EM IMI Screened UCITS ETF — BlackRock · 0.0 % (full portfolio disclosed, October 2026)